Financial Instruments (Tables)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2026 |
Dec. 31, 2025 |
| Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
|
| Schedule of Liabilities Recorded at Fair Value |
The
Company’s financial liabilities measured at fair value on a recurring basis consist of warrant liabilities, valued using Level
1 (quoted market prices) or Level 3 (internally developed option-pricing models) inputs. The Company holds no Level 2 instruments. The
following table presents these liabilities by level of the fair value hierarchy as of September 30, 2026 and December 31, 2025:
Schedule
of Liabilities Recorded at Fair Value
| Liability
(in thousands) | |
Total
Fair Value | | |
Level
1 | | |
Level
3 | | |
Total
Fair Value | | |
Level
1 | | |
Level
3 | |
| | |
September
30, 2026 | | |
December
31, 2025 | |
| Liability | |
Total
Fair Value | | |
Level
1 | | |
Level
3 | | |
Total
Fair Value | | |
Level
1 | | |
Level
3 | |
| PIPE warrants | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | 280 | | |
$ | — | | |
$ | 280 | |
| Public warrants | |
| 240 | | |
| 240 | | |
| — | | |
| 10,896 | | |
| 10,896 | | |
| — | |
| Private placement warrants | |
| — | | |
| — | | |
| — | | |
| 14 | | |
| — | | |
| 14 | |
| Abaca warrants | |
| 58 | | |
| — | | |
| 58 | | |
| 28,430 | | |
| — | | |
| 28,430 | |
| Total
liabilities | |
$ | 298 | | |
$ | 240 | | |
$ | 58 | | |
$ | 39,620 | | |
$ | 10,896 | | |
$ | 28,724 | |
|
The
following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs
in the fair value hierarchy on December 31, 2025 and December 31, 2024:
Schedule of Financial Assets and Liabilities Recorded at Fair Value
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | |
December 31, 2025 | | |
December 31, 2024 | |
| | |
Total Fair Value | | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Unobservable Inputs (Level 3) | | |
Total Fair Value | | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Unobservable Inputs (Level 3) | |
| Description | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Liabilities: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| PIPE warrants | |
$ | 280 | | |
$ | - | | |
$ | 280 | | |
$ | 79,512 | | |
$ | - | | |
$ | 79,512 | |
| Public warrants | |
| 10,896 | | |
| 10,896 | | |
| - | | |
| 246,445 | | |
| 246,445 | | |
| - | |
| Private placement warrants | |
| 14 | | |
| - | | |
| 14 | | |
| 9,632 | | |
| - | | |
| 9,632 | |
| Abaca warrant | |
| 28,430 | | |
| - | | |
| 28,430 | | |
| 1,024,900 | | |
| - | | |
| 1,024,900 | |
| Forward purchase derivative liability | |
| - | | |
| - | | |
| - | | |
| 7,309,580 | | |
| - | | |
| 7,309,580 | |
| Third anniversary payment consideration | |
| - | | |
| - | | |
| - | | |
| 322,000 | | |
| - | | |
| 322,000 | |
|
| Schedule of Non-Recurring Fair Value Measurement |
Schedule of Non-Recurring Fair Value Measurement
| Liability
(as of initial recognition, October 1, 2025) | |
Carrying
Amount | | |
Fair
Value | | |
Level
3 Input | |
| Stand-ready
guarantee liability | |
$ | 2,135,000 | | |
$ | 2,135,000 | | |
$ | 2,135,000 | |
|
Schedule of Non-Recurring Fair Value Measurement
| |
| | |
| | |
| | |
| | |
| |
| | |
December 31, 2025 | |
| | |
Carrying amount $ | | |
Fair value $ | | |
Fair value measurement using | |
| | |
| | |
| | |
Level 1 $ | | |
Level 2 $ | | |
Level 3 $ | |
| Liabilities | |
| | |
| | |
| | |
| | |
| |
| Stand-ready guarantee liability | |
$ | 2,135,000 | | |
$ | 2,135,000 | | |
$ | - | | |
$ | - | | |
$ | 2,135,000 | |
|
| Schedule of Valuation Methodology and Significant Unobservable Inputs |
Schedule
of Valuation Methodology and Significant Unobservable Inputs
| Input |
|
Value
Used |
|
Sensitivity |
| Probability
of Default -Tranches A & B (Ratings 2–5, pooled) |
|
7.25%,
derived from loan level analysis of the portfolio. |
|
An
increase raises fair value |
| Probability
of Default - Tranche C (Rating 9, individually evaluated) |
|
35%,
based on Rating 9 definition, past-maturity status, and personal guarantees |
|
An
increase raises fair value |
| Loss
Given Default - Tranches A & B |
|
25.00%
for Tranche A and 35% for Tranche B, inclusive of 13% cannabis-specific qualitative premium reflecting court access limitations,
collateral possession restrictions, and refinancing risk |
|
An
increase raises fair value |
| Loss
Given Default - Tranche C (uncollateralized gap) |
|
50%,
representing the midpoint of the Rating 9 anticipated loss range applied to the uncollateralized exposure |
|
An
increase raises fair value |
| Stand-Ready
Risk Premium |
|
120%
loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio illiquidity,
and six-year guarantee term commitment |
|
An
increase raises fair value |
| Discount
Rate |
|
4.0%
risk-free rate (6-year Treasury) |
|
An
increase reduces fair value |
| Weighted
Average Payout Timing |
|
Tranche
A: 4 years; Tranche B: 3 years; Tranche C: 2 years; Stand-ready premium: 3 years — based on the portfolio’s contractual
maturity profile |
|
A
longer weighted average payout timing reduces fair value |
|
The
ASC 460 Guarantee liability was classified as Level 3 because its fair value was determined using significant unobservable inputs for
which there is no active market. The following table summarizes the valuation methodology and significant unobservable inputs used in
the Level 3 measurement:
Schedule of Valuation Methodology and Significant Unobservable Inputs
| Input |
|
Value
Used |
|
Sensitivity |
| Probability of Default -Tranches A & B (Ratings
2-5, pooled) |
|
7.25%, derived from loan level analysis of the portfolio. |
|
An increase raises fair value |
| Probability of Default - Tranche C (Rating 9, individually
evaluated) |
|
35%, based on Rating 9 definition, past-maturity status,
and personal guarantees |
|
An increase raises fair value |
| Loss Given Default - Tranches A & B |
|
25.00% for Tranche A and 35% for Tranche B, inclusive
of 13% cannabis-specific qualitative premium reflecting court access limitations, collateral possession restrictions, and
refinancing risk |
|
An increase raises fair value |
| Loss Given Default - Tranche C (uncollateralized gap) |
|
50%, representing the midpoint of the Rating 9 anticipated
loss range applied to the uncollateralized exposure |
|
An increase raises fair value |
| Stand-Ready Risk Premium |
|
120%
loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio
illiquidity, and six-year guarantee term commitment |
|
An increase raises fair value |
| Discount Rate |
|
4.0%
risk-free rate (6-year Treasury) |
|
An increase reduces fair value |
| Weighted Average Payout Timing |
|
Tranche A: 4 years; Tranche B: 3 years; Tranche C:
2 years; Stand-ready premium: 3 years - based on the portfolio’s contractual maturity profile |
|
A longer weighted average payout timing reduces fair
value |
|
| Schedule of Carrying Amount and Fair Value of Financial Instruments |
The
following tables present the carrying amounts and fair values of the Company’s financial instruments, by level of the fair value
hierarchy, as of September 30, 2026 and December 31, 2025. In each case, carrying value approximates fair value.
Schedule
of Carrying Amount and Fair Value of Financial Instruments
| September
30, 2026 | |
Carrying
Amount | | |
Fair
Value | | |
Level |
| Assets | |
| | | |
| | | |
|
| Cash and cash equivalents | |
$ | 4,396,069 | | |
$ | 4,396,069 | | |
Level 1 |
| Liabilities | |
| | | |
| | | |
|
| Deferred consideration | |
| 3,000,000 | | |
| 3,000,000 | | |
Level 1 |
| Public warrants | |
| 240 | | |
| 240 | | |
Level 1 |
| Abaca warrants | |
| 58 | | |
| 58 | | |
Level 3 |
| December 31,
2025 | |
Carrying
Amount | | |
Fair
Value | | |
Level |
| Assets | |
| | | |
| | | |
|
| Cash and cash equivalents | |
$ | 6,779,040 | | |
$ | 6,779,040 | | |
Level 1 |
| Investment in preferred securities | |
| 1,450,000 | | |
| 1,450,000 | | |
Level 3 |
| Liabilities | |
| | | |
| | | |
|
| Deferred consideration | |
| 3,000,000 | | |
| 3,000,000 | | |
Level 1 |
| Public warrants | |
| 10,896 | | |
| 10,896 | | |
Level 1 |
| Private placement warrants | |
| 14 | | |
| 14 | | |
Level 3 |
| PIPE warrants | |
| 280 | | |
| 280 | | |
Level 3 |
| Abaca warrants | |
| 28,430 | | |
| 28,430 | | |
Level 3 |
|
Schedule
of Carrying Amounts and Fair Values of Financial Instruments
| | |
| | |
| | |
Level
1
$ | | |
Level
2
$ | | |
Level
3
$ | |
| | |
December
31, 2025 | |
| | |
Carrying
amount
$ | | |
Fair
value
$ | | |
Fair
value measurement using | |
| | |
| | |
| | |
Level
1
$ | | |
Level
2
$ | | |
Level
3
$ | |
| Assets | |
| | |
| | |
| | |
| | |
| |
| Cash and cash
equivalents | |
$ | 6,779,040 | | |
$ | 6,779,040 | | |
$ | 6,779,040 | | |
$ | - | | |
$ | - | |
| Forward purchase agreement | |
| | | |
| | | |
| | | |
| | | |
| | |
| Loans | |
| | | |
| | | |
| | | |
| | | |
| | |
| Investment in preferred
securities | |
| 1,450,000 | | |
| 1,450,000 | | |
| - | | |
| - | | |
| 1,450,000 | |
| Liabilities | |
| | | |
| | | |
| | | |
| | | |
| | |
| Deferred consideration | |
| 3,000,000 | | |
| 3,000,000 | | |
| 3,000,000 | | |
| - | | |
| - | |
| Public warrants | |
| 10,896 | | |
| 10,896 | | |
| 10,896 | | |
| - | | |
| - | |
| Private placement warrants | |
| 14 | | |
| 14 | | |
| - | | |
| - | | |
| 14 | |
| PIPE warrants | |
| 280 | | |
| 280 | | |
| - | | |
| - | | |
| 280 | |
| Abaca warrants | |
| 28,430 | | |
| 28,430 | | |
| - | | |
| - | | |
| 28,430 | |
| | |
| | |
| | |
Level
1
$ | | |
Level
2
$ | | |
Level
3
$ | |
| | |
December
31, 2024 | |
| | |
Carrying
amount
$ | | |
Fair
value
$ | | |
Fair
value measurement using | |
| | |
| | |
| | |
Level
1
$ | | |
Level
2
$ | | |
Level
3
$ | |
| Assets | |
| | |
| | |
| | |
| | |
| |
| Cash and cash equivalents | |
$ | 2,324,647 | | |
$ | 2,324,647 | | |
$ | 2,324,647 | | |
$ | - | | |
$ | - | |
| Forward purchase agreement | |
| 4,584,221 | | |
| 4,584,221 | | |
| 4,584,221 | | |
| - | | |
| - | |
| Loans | |
| 360,552 | | |
| 359,505 | | |
| - | | |
| - | | |
| 359,505 | |
| Liabilities | |
| | | |
| | | |
| | | |
| | | |
| | |
| Deferred consideration | |
| 3,016,343 | | |
| 3,016,343 | | |
| 3,016,343 | | |
| - | | |
| - | |
| Senior secured promissory note | |
| 11,004,173 | | |
| 10,221,652 | | |
| - | | |
| - | | |
| 10,221,652 | |
| Public warrants | |
| 246,445 | | |
| 246,445 | | |
| 246,445 | | |
| - | | |
| - | |
| Private placement warrants | |
| 9,632 | | |
| 9,632 | | |
| - | | |
| - | | |
| 9,632 | |
| PIPE warrants | |
| 79,512 | | |
| 79,512 | | |
| - | | |
| - | | |
| 79,512 | |
| Abaca warrants | |
| 1,024,900 | | |
| 1,024,900 | | |
| - | | |
| - | | |
| 1,024,900 | |
| Third anniversary payment consideration | |
| 322,000 | | |
| 322,000 | | |
| - | | |
| - | | |
| 322,000 | |
| Forward purchase derivative | |
| 7,309,580 | | |
| 7,309,580 | | |
| - | | |
| - | | |
| 7,309,580 | |
|
| Schedule of Fair Value Assets Measured on Recurring Basis |
The
following tables present the changes in the Company’s Level 3 liabilities measured at fair value on a recurring basis for the nine
months ended September 30, 2026 and September 30, 2025. All changes during each period were attributable to fair value adjustments, with
no purchases, issuances, or settlements:
Schedule
of Fair Value Assets Measured on Recurring Basis
| Nine Months
Ended September 30, 2026 | |
PIPE
Warrants | | |
Abaca
Warrants | | |
Private
Placement Warrants | |
| Balance, January 1, 2026 | |
$ | 280 | | |
$ | 28,430 | | |
$ | 14 | |
| Fair value adjustment | |
| (280 | ) | |
| (28,372 | ) | |
| (14 | ) |
| Exchanged for Series B Convertible Preferred Stock and Series B Warrants | |
| | | |
| | | |
| | |
| Balance, September 30,
2026 | |
$ | - | | |
$ | 58 | | |
$ | - | |
| Nine Months
Ended September 30, 2025 | |
PIPE
Warrants | | |
Abaca
Warrants | | |
Private
Placement Warrants | | |
Third
Anniversary Payment Consideration | | |
Forward
Purchase Derivative | |
| Balance, January 1, 2025 | |
$ | 79,512 | | |
$ | 1,024,900 | | |
$ | 9,632 | | |
$ | 322,000 | | |
$ | 7,309,580 | |
| Fair value adjustment | |
| (40,439 | ) | |
| (313,986 | ) | |
| (5,669 | ) | |
| (63,132 | ) | |
| - | |
| Exchanged for Series B Convertible Preferred Stock and Series B Warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| (7,309,580 | ) |
| Balance, September 30,
2025 | |
$ | 39,073 | | |
$ | 710,914 | | |
$ | 3,963 | | |
$ | 258,868 | | |
$ | - | |
|
The
change in the liability measured at fair value on a recurring basis for which the Company has utilized Level 3 inputs to determine fair
value are presented in the following table:
Schedule of Fair Value Assets Measured on Recurring Basis
| | |
PIPE
Warrants | | |
Abaca
Warrant | | |
Private
Placement Warrants | | |
Third
anniversary payment consideration | | |
Forward
Purchase Derivative | |
| | |
For
the Year Ended December 31, 2025 | | |
| |
| | |
PIPE
Warrants | | |
Abaca
Warrant | | |
Private
Placement Warrants | | |
Third
anniversary payment consideration | | |
Forward
Purchase Derivative | |
| Balance, January 1, 2025 | |
$ | 79,512 | | |
$ | 1,024,900 | | |
$ | 9,632 | | |
$ | 322,000 | | |
$ | 7,309,580 | |
| Fair value adjustment | |
| (79,232 | ) | |
| (996,470 | ) | |
| (9,618 | ) | |
| (63,133 | ) | |
| - | |
| Exchanged for Common Stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
258,867 |
|
|
|
- |
|
| Exchanged for Series B
Convertible Preferred Stock and Series B Warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| (7,309,580 | ) |
| Balance, December 31, 2025 | |
$ | 280 | | |
$ | 28,430 | | |
$ | 14 | | |
$ | - | | |
$ | - | |
| | |
PIPE
Warrants | | |
Abaca
Warrant | | |
Private
Placement Warrants | | |
Third
anniversary payment consideration | | |
Forward
Purchase Derivative | |
| | |
For
the Year ended December 31, 2024 | | |
| |
| | |
PIPE
Warrants | | |
Abaca
Warrant | | |
Private
Placement Warrants | | |
Third
anniversary payment consideration | | |
Forward
Purchase Derivative | |
| Balance, January 1, 2024 | |
$ | 273,124 | | |
$ | 3,384,085 | | |
$ | 25,070 | | |
$ | 810,000 | | |
$ | 7,309,580 | |
| Beginning balance | |
$ | 273,124 | | |
$ | 3,384,085 | | |
$ | 25,070 | | |
$ | 810,000 | | |
$ | 7,309,580 | |
| Fair value adjustment | |
| (193,612 | ) | |
| (2,359,185 | ) | |
| (15,438 | ) | |
| (488,000 | ) | |
| - | |
| Balance, December 31, 2024 | |
$ | 79,512 | | |
| 1,024,900 | | |
$ | 9,632 | | |
$ | 322,000 | | |
$ | 7,309,580 | |
| Ending balance | |
$ | 79,512 | | |
| 1,024,900 | | |
$ | 9,632 | | |
$ | 322,000 | | |
$ | 7,309,580 | |
|
| Schedule of Level 3 Fair Value Measurements Inputs |
|
The
following table provides quantitative information regarding Level 3 fair value measurements inputs for the third anniversary payment
consideration as of their measurement dates:
Schedule of Fair Value Measurements Inputs for the Third Anniversary Payment Consideration
| |
|
December
31, 2024 | |
| |
|
| |
| Stock price |
|
$ | 108.00 | |
| Payment date |
|
| 10/15/2025 | |
| Third anniversary consideration |
|
$ | 1,500,000 | |
| Risk free interest rate |
|
| 4.2 | % |
| Market discount rate |
|
| 5.8 | % |
| Remaining term in years |
|
| 0.75 | |
| Expected volatility |
|
| 86.2 | % |
|
| Schedule of Financial Instruments |
Schedule
of Financial Instruments
| Origination
Quarter | |
#
Loans | | |
PD | | |
LGD
(incl. cannabis qualitative premium) | | |
Stand-Ready
Risk Premium Loading | |
Discount
Rate | | |
Weighted
Avg Payout |
| Three months ended September
30, 2026 | |
| 1 | | |
| 7.25 | % | |
| 25 | % | |
120% of expected loss | |
| 5.0 | % | |
5 years |
| Origination
Quarter | |
#
Loans | | |
PD | | |
LGD
(incl. cannabis qualitative premium) | | |
Stand-Ready
Risk Premium Loading | |
Discount
Rate | |
Weighted
Avg Payout |
| Nine months ended September
30, 2026 | |
| 3 | | |
| 7.25 | % | |
| 25 | % | |
120% of expected loss | |
4.4% to 5.0% | |
5 years |
|
|
| Warrant [Member] |
|
|
| Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
|
| Schedule of Level 3 Fair Value Measurements Inputs |
The
PIPE warrants, private placement warrants, and Abaca warrants are valued using the Black-Scholes-Merton option pricing model. The following
tables present the significant unobservable inputs used in these valuations as of September 30, 2026 and December 31, 2025:
Schedule
of Level 3 Fair Value Measurements Inputs
| As of September
30, 2026 | |
PIPE
Warrants | | |
Private
Placement Warrants | | |
Abaca
Warrants | |
| Exercise price | |
$ | 1,200 | | |
$ | 2,760 | | |
$ | 480 | |
| Share price | |
$ | 1.50 | | |
$ | 1.50 | | |
$ | 1.50 | |
| Expected term (years) | |
| 0.99 | | |
| 0.99 | | |
| 2.07 | |
| Volatility | |
| 117 | % | |
| 117 | % | |
| 117 | % |
| Risk-free rate | |
| 4.5 | % | |
| 4.5 | % | |
| 4.5 | % |
| As of December
31, 2025 | |
PIPE
Warrants | | |
Private
Placement Warrants | | |
Abaca
Warrants | |
| Exercise price | |
$ | 1,200 | | |
$ | 2,760 | | |
$ | 480 | |
| Share price | |
$ | 12.72 | | |
$ | 12.72 | | |
$ | 12.72 | |
| Expected term (years) | |
| 1.74 | | |
| 1.74 | | |
| 2.82 | |
| Volatility | |
| 115 | % | |
| 115 | % | |
| 115 | % |
| Risk-free rate | |
| 3.5 | % | |
| 3.5 | % | |
| 3.5 | % |
|
The
following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement
warrants, public warrants, third anniversary payment consideration and Abaca warrants as of their measurement dates:
Schedule of Level 3 Fair Value Measurements Inputs
| | |
PIPE
Warrants | | |
Private
Warrants | | |
Third
Anniversary Payment Consideration | | |
Abaca
Warrants | | |
PIPE
Warrants | | |
Private
Warrants | | |
Third
Anniversary Payment Consideration | | |
Abaca
Warrants | |
| | |
As
on December 31, 2025 | | |
| | |
As
on December 31, 2024 | | |
| |
| | |
PIPE
Warrants | | |
Private
Warrants | | |
Third
Anniversary Payment Consideration | | |
Abaca
Warrants | | |
PIPE
Warrants | | |
Private
Warrants | | |
Third
Anniversary Payment Consideration | | |
Abaca
Warrants | |
| Exercise price | |
$ | 1,200 | | |
$ | 2,760.00 | | |
$ | - | | |
$ | 480.00 | | |
$ | 1,200.00 | | |
$ | 2,760.00 | | |
$ | - | | |
$ | 480.00 | |
| Share price | |
$ | 12.72 | | |
$ | 12.72 | | |
$ | - | | |
$ | 12.72 | | |
$ | 108.00 | | |
$ | 108.00 | | |
$ | 108.00 | | |
$ | 108.00 | |
| Expected term (years) | |
| 1.7 | | |
| 1.7 | | |
| - | | |
| 2.8 | | |
| 2.7 | | |
| 2.7 | | |
| 0.8 | | |
| 3.87 | |
| Volatility | |
| 115 | % | |
| 115 | % | |
| - | | |
| 115 | % | |
| 103 | % | |
| 103 | % | |
| 103 | % | |
| 103 | % |
| Risk-free rate | |
| 3.5 | % | |
| 3.5 | % | |
| - | | |
| 3.5 | % | |
| 4.3 | % | |
| 4.3 | % | |
| 4.3 | % | |
| 4.3 | % |
| Measurement input | |
| 3.5 | % | |
| 3.5 | % | |
| - | | |
| 3.5 | % | |
| 4.3 | % | |
| 4.3 | % | |
| 4.3 | % | |
| 4.3 | % |
|